Case number 2022-2167
AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 4, 2022 | 0 | ASTRAZENECA AB v. ZYDUS PHARMACEUTICALS (USA) INC. [ORDER] [nonprecedential] (0) |
| Nov 29, 2022 | 13 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [12] filed by Appellant Zydus Pharmaceuticals (USA) Inc.; issuing mandate. Service as of this date by the Clerk of Court. [887024] [ALK] [Entered: 11/29/2022 04:29 PM] (2) |
| Nov 23, 2022 | 12 | MOTION of Appellant Zydus Pharmaceuticals (USA) Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 11/23/2022 by email. [886376] [22-2167] [Zhibin Li] [Entered: 11/23/2022 11:45 AM] (6) |
| Oct 25, 2022 | 10 | **TEXT ONLY** ORDER granting motion to extend time to file brief [9] filed by Appellant Zydus Pharmaceuticals (USA) Inc. The opening brief is due 11/30/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [880049] [ALK] [Entered: 10/25/2022 09:07 AM] (0) |
| Oct 25, 2022 | 11 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [9], ERROR: Appellant's motion does not include a Certificate of Interest. CORRECTION: For future relevant filings, please include a certificate of interest as required by FCR 47.4(b). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [880051] [ALK] [Entered: 10/25/2022 09:08 AM] (0) |
| Oct 24, 2022 | 9 | MOTION of Appellant Zydus Pharmaceuticals (USA) Inc. to extend the time to 11/30/2022 to file brief. Service: 10/24/2022 by email. [879902] [22-2167] [Zhibin Li] [Entered: 10/24/2022 03:37 PM] (7) |
| Sep 13, 2022 | 5 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [2], Doc No. [3], Doc No. [4], ERROR: Appellant's entry of appearance, certificate of interest, and docketing statement use a non-compliant signature format. CORRECTION: An electronic signature must follow the format prescribed by Fed. Cir. R. 25(g)(1)-(2). Please use a compliant signature format on future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [871363] [ALK] [Entered: 09/13/2022 09:59 AM] (0) |
| Sep 13, 2022 | 6 | Entry of appearance for Charles E. Lipsey; John D. Livingstone; Jill K. MacAlpine; M. David Weingarten; Ryan O'Quinn; Matthew J. Hlinka as counsel for Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871471] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:26 PM] (2) |
| Sep 13, 2022 | 7 | Certificate of Interest for Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871473] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:28 PM] (3) |
| Sep 13, 2022 | 8 | Docketing Statement for the Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871475] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:32 PM] (2) |
| Sep 12, 2022 | 2 | Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; Alan B. Clement; Zhibin Li as counsel for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871121] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:11 AM] (2) |
| Sep 12, 2022 | 3 | Certificate of Interest for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871122] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:15 AM] (3) |
| Sep 12, 2022 | 4 | Docketing Statement for the Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871123] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:17 AM] (2) |
| Aug 30, 2022 | 1 | Appeal docketed. Received: 08/24/2022. [868848]Entry of Appearance is due on 09/13/2022. Certificate of Interest is due on 09/13/2022. Docketing Statement is due on 09/13/2022. Appellant's brief is due on 10/31/2022. [ALK] [Entered: 08/30/2022 09:53 AM] (26) |
